Pharmaceutical Strategy and Innovation: An Academics Perspective
✍ Scribed by Ian R. Baxendale; John J. Hayward; Steven V. Ley; Geoffrey K. Tranmer
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 830 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1860-7179
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The impact of cisplatin on cancer chemotherapy cannot be denied. Over the past 20 years, much effort has been dedicated to discover new platinum‐based anticancer agents that are superior to cisplatin or its analogue, carboplatin. Most structural modifications are based on changing one o
## Abstract First‐year students in genetics at the University of KwaZulu‐Natal, South Africa, attend two general biology modules, one in each semester. Teaching involves four formal lectures per week of 45 min each, one 3‐h practical, and one lecture period tutorial. These students, graduating from
The question is if this is the right strategy for an automobile company that wants to offer new low cost and/or differentiated products to its customers worldwide. \* This article advances three points: \* \* Second, to get the best out of the strategy, in any case, Ford must implement it well, moul
## Abstract The vertebrate limb has provided evolutionary and developmental biologists with grist for theory and experiment for at least a century. Its most salient features are its pattern of discrete skeletal elements, the general proximodistal increase in element number as development proceeds,
Using a case study, this paper takes the phenomenon of knowledge-based economies (Department of Trade and Industry, 1998) and the concept of knowledge as the basis of a dynamic theory of the firm (Spender, 1996), and integrates them to produce a view of strategy innovation. It does so by taking Nona